David A. Ramsay

2011

In 2011, David A. Ramsay earned a total compensation of $459.9K as Vice President and Chief Financial Officer at Halozyme Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$56,252
Option Awards$80,057
Salary$253,351
Stock Awards$62,531
Other$7,712
Total$459,903

Ramsay received $253.4K in salary, accounting for 55% of the total pay in 2011.

Ramsay also received $56.3K in non-equity incentive plan, $80.1K in option awards, $62.5K in stock awards and $7.7K in other compensation.

Rankings

In 2011, David A. Ramsay's compensation ranked 8,313th out of 10,747 executives tracked by ExecPay. In other words, Ramsay earned more than 22.6% of executives.

ClassificationRankingPercentile
All
8,313
out of 10,747
23rd
Division
Manufacturing
3,059
out of 3,960
23rd
Major group
Chemicals And Allied Products
767
out of 1,038
26th
Industry group
Drugs
554
out of 786
30th
Industry
Biological Products, Except Diagnostic Substances
95
out of 162
41st
Source: SEC filing on April 7, 2014.

Ramsay's colleagues

We found six more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2011.

2011

James Shaffer

Halozyme Therapeutics

Vice President and Chief Commercial Officer

2011

Jean Liu

Halozyme Therapeutics

General Counsel

2011

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2011

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2011

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2011

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

You may also like